We signed the  Collaboration Agreement with Sumitomo Dainippon Pharma Co., Ltd. as per attached.

Sumitomo Dainippon Pharma has accumulated wealth of knowledge based on their achievement of drug discovery research in the area of psychiatry and neurology disorders, while Luxna Biotech has accumulated drug discovery technology for oligonucleotides therapeutics based on our bridged nucleic acids technology. By combing those technologies, we have reached an agreement to create oligonucleotide therapeutics for multiple intractable neurological diseases which target specific genes.